Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead -- 2nd Update
By Billy Gray Novartis expects sales and earnings growth to continue next year despite recent patent expirations, after the Swiss drugmaker reported a higher third-quarter net profit. The...